TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/20/20 20:01 | 10/20/20 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Frazier Life Sciences Ix, L.P. | WA | T | P.d | 5,000 | 16.00 | 0 | 313 | 19 | 1,917 | D | |||||||||||||||
3/3/20 18:59 | 3/3/20 | PASG | Passage Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Frazier Life Sciences Ix, L.P. | WA | T | P.d | 9,900 | 18.00 | 0 | 550 | 12 | 5,009 | D | |||||||||||||||
10/30/19 17:04 | 10/29/19 | PHAT | Phathom Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Frazier Life Sciences Ix, L.P. | WA | T | P.d | 20,000 | 19.00 | 0 | 1,053 | 17 | 7,284 | D | |||||||||||||||
7/24/19 16:17 | 7/22/19 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Frazier Life Sciences Ix, L.P. | CA | T | P.d | 6,750 | 15.00 | 0 | 450 | 14 | 3,567 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |